Beyond Air® Reports Financial Results for Second Quarter of Fiscal Year 2021 and Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Beyond Air, Inc. (XAIR) Reports In-Line Q1 EPS, Revenues Beat
November 11, 2020 4:32 PM ESTBeyond Air, Inc. (NASDAQ: XAIR) reported Q1 EPS of ($0.30), in-line with the analyst estimate of ($0.30). Revenue for the quarter came in at $349.6 thousand versus the consensus estimate of $120 thousand.
Over the past few months we have achieved several significant milestones, both regulatory and clinical, across our development pipeline. Most notably, we filed a PMA for the LungFit PH system for the treatment of PPHN, which will be subject to the standard 180-day FDA... More
